A monster in my medicine chest? Could this be by design

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28
511
A monster in my medicine chest?

Could this be by design by the pharma thugs?

New Study Unearths Paradox: Opioids Cause Chronic Pain

http://www.greenmedinfo.com/blog/new-study-un...ronic-pain

We all know that surgery is often painful, but a new study will have you thinking twice before you fill that pain-pill prescription. As this new science reveals, even a few days of opiates can set you up for a longer, more painful recovery

A just-released study has called into question the feasibility of using opioids to manage post-surgical pain. Rats given repeated doses of morphine experienced inflammation and pain for three weeks longer than non-medicated test subjects.

On April 16, 2018, researchers from the University of Colorado at Boulder released an animal study[1] examining the effect of opioids on pain, post-surgery. In the study, an exploratory abdominal surgery was conducted on male rats called a laparotomy. Laparotomies are routine surgical procedures in the United States, often conducted when pelvic disorders are suspected, and one for which opioids are the standard post-surgical pain management prescription.

Rats were treated with moderate doses of morphine immediately post-surgery for seven days, while a control group was given saline solution. A further experiment was conducted to determine the effects of two-days of gradual tapering from morphine after eight days of dosing, versus the effects of abrupt withdrawal. A third experiment fed subjects morphine for seven days prior to laparotomy. Rats were then measured for sensitivity to touch, as well as expression of inflammatory markers in the spinal cord.

In a surprise to researchers, results showed that opioid pain treatments prolonged pain for three weeks as compared to non-medicated subjects given the saline solution. Opioids further had the effect of “priming” specialized, immune system cells in the spinal cord to become more sensitive to pain. The longer the rats received morphine, the longer they were reactive to pain. Tapering from the medication had no effect on pain sensitivity as compared to quitting cold-turkey. Researchers concluded that “morphine can have a deleterious effect on postoperative pain,” and suggested that longitudinal studies be performed to determine if this same effect can be seen in humans.

In an interview with Science Daily, the study authors are well-aware of the implications for current pain-management procedures in most hospitals and pain clinics, as well as how this study might impact the nationwide debate about opioid abuse. According to senior author Linda Watkins, "This indicates that there is another dark side of opiates that many people don't suspect. It shows that trauma, including surgery, in combination with opiates can lead to chronic pain."

Professor Watkins describes a “one-two hit” on the immune system, that comes first from the surgery, and then from the opioid medication, sending repeat signals to the body that it is “not OK.” It’s as if the morphine is perceived by the body as a secondary threat, coming at a time when it is already compromised. Watkins describes the primed response by glial cells, stating that they create “a more enduring state of inflammation and sometimes local tissue damage,” problems only experienced by the rats exposed to morphine.

This opens the door to a broader methodological debate about how the body—and Western medicine—manages pain. Are opioids, if not all pharmaceutical medications, hijacking the body’s innate response systems? Millions of years of evolution have created a natural intelligence that is far superior to the medical interventions that mankind implements. Are prescriptions for pain-management merely shooting us in our collective foot?

This study is not alone in its findings. A 2016 animal study[2] found that only a few days treatment with opioids for chronic nerve pain intensified and prolonged pain for months due to increased systemic inflammation. There are limited human studies that also support reexamining opiates.[3],[4] The nation’s ongoing opioid crisis undoubtedly supports the need for immediate exploration of non-addictive, holistic treatments for pain.

Researchers admit that the intention behind opioid therapy is to limit pain and suffering—not prolong it—and that more human studies are necessary to determine if alternative painkillers can effectively replace opioids, without the negative side effects.

For additional reasearch on Natural Remedies for Pain, visit the GreenMedInfo database on the subject.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

South Dakota's BEES Launch: Child Care Assistance Goes Live

Updated Category News Views 70

RedMane and South Dakota DSS: A New Milestone Talk about a leap into the digital age. South Dakota's Department of Social Services, teaming up with RedMane Technology, has just rolled out the Child Care Assistance Program on their BEES platform. That’s Benefits Eligibility and Enrollment System for those not keeping track. It represents a significant step in making life...

Continue Reading
Hexaware's Q3 Revenue Boosts, Faces Pressures on Margins

Updated Category News Views 90

Hexaware Registers Revenue Growth Amid EBIT Challenges Hexaware Technologies (NSE: HEXT) just dropped their Q3 numbers like a heavyweight fighter showing off new moves—and boy, there's plenty to chew on. Revenue hit $411.9 million, a decent 4.3% climb from last year. But dig deeper and you'll find some bruises hiding under that revenue glow: EBIT took a 13.5% yearly...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 217

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
Ameritas Hires Actuarial Veteran as VP in Strategic Move

Updated Category News Views 137

Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...

Continue Reading
AST SpaceMobile Suit Seeks Lead Plaintiff by November 13

Updated Category News Views 86

The Legal Rigmarole The market's got its knickers in a twist over AST SpaceMobile, folks. If you've been dabbling in NASDAQ:ASTS between March '25 and mid-July '26, it's time to perk up those ears. The legal eagles at Robbins Geller Rudman & Dowd LLP are rallying the troops for a class action lawsuit with you front and center. Deadline's looming on November 13, 2026, for...

Continue Reading
Keeping Halloween Safe and Fun with AHN Tips

Updated Category News Views 119

Trick or Treat the Safe Way Ah, Halloween. A time when you don't just get to pretend to be someone else; you get to pile on the candy like it's a second job. But hold up! Before your pint-sized Dracula sprints into the foggy night, heed some wisdom from the folks at Allegheny Health Network. They aren't just offering another bowl of sugar-coated advice; they've got...

Continue Reading
Randi Cruz Steps Up as CFO at Bridge Legal

Updated Category News Views 24

A Key Milestone for Bridge Legal Here's a juicy tidbit for you: Bridge Legal is shaking things up by promoting Randi Cruz to Chief Financial Officer. It's a big deal, folks, especially when you consider that this company is one of those movers and shakers in the legal tech world. Randi's journey at Bridge Legal hasn't been a walk in the park, but more of a strategic...

Continue Reading
DayOne's Bold Energy Moves With Sembcorp for Asia Growth

Updated Category News Views 68

It seems the digital world and power supply have locked in a new dance as DayOne Data Centers teams up with Sembcorp Utilities. It's high time we gave this story a solid look, especially with data centers gobbling energy faster than my old trading partner downs an espresso. Tackling Energy Constraints Head-On The digital infrastructure beast is hungry for power, and...

Continue Reading
West Fraser Tackles Grim Quarter: Indefinite Mill Closures

Updated Category News Views 103

Bracing For Impact: The Tough Truth About West Fraser's Recent Moves Things are looking a bit bleak over at West Fraser Timber Co. They've just dropped their Q3 2026 results, ringing the bell with a hefty $80 million loss. As if that wasn't enough, the company's decided to indefinitely curtail a couple of mills—one in Lanett, Alabama and the other in Leola, Arkansas....

Continue Reading
H.R. 10549: Hope Charities Pushes for Pharmacy Freedom

Updated Category News Views 92

Hope Charities Takes a Stand for Patients In Prairieville, Hope Charities is throwing its weight behind a bill they believe is brewing up a patient revolution. The Patients Choice in Specialty Pharmacy Act, otherwise known as H.R. 10549, sparked by Representatives Neal Dunn and Joe Wilson, tackles the comfortable partnerships some insurers have been enjoying with their...

Continue Reading

Top 5 Most Recently Viewed Articles

Citius Oncology Secures $9 Million in Financing Through Offerings

Updated Category News Views 156

Citius Oncology's Latest Financial Move Citius Oncology, Inc. is making significant strides in the oncology space with its recent announcement regarding a financing initiative worth approximately $9 million. The company, which specializes in pioneering cancer treatments, has entered into a securities purchase agreement with an institutional investor to facilitate a...

Continue Reading
Investors Alert: Marex Group plc Faces Class Action Lawsuit

Updated Category News Views 174

Marex Group plc Class Action Update for Interested Investors Attention to all investors in Marex Group plc (NASDAQ: MRX), a significant announcement has surfaced regarding a class action lawsuit that may have implications for shareholders. The firm of Levi & Korsinsky, LLP has notified stakeholders about legal proceedings aimed at addressing potential losses incurred due...

Continue Reading
Investors Urged to Take Action in Methode Electronics Case

Updated Category News Views 57

Introduction to the Methode Electronics Case In a significant development within the financial and legal sectors, investors in Methode Electronics, Inc. are being encouraged to lead a securities fraud class action lawsuit. This situation has arisen due to substantial losses experienced by shareholders during a particular class period. Class Period and Its Implications The...

Continue Reading
NEST Empowers Youth with Startup Opportunities

Updated Category News Views 7

NEST: Bridging the Gap in Youth Entrepreneurship In the hustle of Atlanta, there's a nonprofit doing something that makes you sit up and take notice. We're talking about NEST—New Entrepreneurs Shaping Tomorrow. It's not just a fancy name; it's a mission. They’re arming students, who would otherwise be flying blind in the business world, with the financial education...

Continue Reading
Transform Your Investment: The Growth of Curtiss-Wright Stock

Updated Category News Views 143

The Incredible Journey of Curtiss-Wright Stock Curtiss-Wright Corporation (NYSE: CW) has shown impressive performance over the past 15 years, beating the market averages by 8.53% each year, resulting in an average annual return of 20.86%. With a market capitalization nearing $20.03 billion, it's evident that this company has made quite a mark on investors’ portfolios....

Continue Reading